# Sertraline vs. Venlafaxine XR

> **NCT00179283** · PHASE3 · COMPLETED · sponsor: **Vanderbilt University** · enrollment: 20 (—)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** sertraline
- **DRUG:** venlafaxine XR

## Key facts

- **NCT ID:** NCT00179283
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-04
- **Primary completion:** —
- **Final completion:** 2003-04
- **Target enrollment:** 20 (—)
- **Last updated:** 2015-06-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00179283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00179283, "Sertraline vs. Venlafaxine XR". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT00179283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*